4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-016979
President and CEO sold 20,000 shares at $10.13 ($202,600)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-03-07 | Sale | −20,000 | $10.13 | $202,600 | 7,704,439 | D |
| Derivatives | |||||||
| Jiang Wenbin President and CEO | 2023-03-03 | Grant or award · Employee Stock Option (Right to Buy) | +284,900 | 284,900 | D | ||
| Jiang Wenbin President and CEO | 2023-03-03 | Grant or award · Restricted Stock Units | +188,501 | 188,501 | D | ||
| Open-market sales · 20,000 sh · avg $10.13 · $202,600 | |||||||
Loading xslF345X03/doc4.xml…